MaxCyte, Inc. (LON:MXCT – Get Free Report)’s share price crossed below its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of GBX 0.90 and traded as low as GBX 0.73. MaxCyte shares last traded at GBX 0.75, with a volume of 843,894 shares changing hands.
MaxCyte Price Performance
The firm has a market cap of £800,050.48, a P/E ratio of -0.02 and a beta of 1.13. The business’s fifty day simple moving average is GBX 0.90 and its 200-day simple moving average is GBX 1.33. The company has a current ratio of 12.39, a quick ratio of 14.38 and a debt-to-equity ratio of 9.70.
About MaxCyte
MaxCyte is a leading cell-engineering company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics and to support innovative, cell-based research. MaxCyte brings best-in-class technology paired with ongoing support designed to facilitate complex engineering of a wide variety of cells and payloads, with the aim of advancing new treatment options for patients. For over 20 years, MaxCyte has been perfecting the art of cell-engineering, venturing beyond today’s process to innovate tomorrow’s solutions.
See Also
Receive News & Ratings for MaxCyte Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MaxCyte and related companies with MarketBeat.com's FREE daily email newsletter.
